Cruiser Capital Advisors, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 44 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cruiser Capital Advisors, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$301,000
-5.9%
36,888
+12.2%
0.15%0.0%
Q2 2018$320,000
-6.2%
32,888
-16.3%
0.15%
-29.4%
Q1 2018$341,000
-30.7%
39,2750.0%0.22%
-42.6%
Q4 2017$492,00039,2750.38%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 610,045$2,014,0000.47%
ETF MANAGERS GROUP, LLC 1,814,328$5,987,0000.13%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 72,169$238,0000.06%
Bernardo Wealth Planning LLC 27,219$89,0000.03%
Affinity Asset Advisors, LLC 13,285$44,0000.02%
ALGERT GLOBAL LLC 20,778$69,0000.02%
ZEKE CAPITAL ADVISORS, LLC 49,700$164,0000.01%
Founders Capital Management 2,000$18,0000.01%
King Wealth Management Group 16,000$53,0000.01%
Penserra Capital Management LLC 129,252$425,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders